Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Completed · Phase 3 · Has a placebo group

Conditions studied: Neurotoxicity, Pain

In brief

RATIONALE: Gabapentin may be effective in relieving pain and other symptoms of peripheral neuropathy. It is not yet known if gabapentin is effective in treating peripheral neuropathy in cancer patients undergoing chemotherapy. PURPOSE: Randomized phase III trial to determine the effectiveness of gabapentin in treating pain and other symptoms of peripheral neuropathy in cancer patients undergoing chemotherapy.

Key facts

Study ID
NCT00027963
Run by
Alliance for Clinical Trials in Oncology
People needed
100
Starts
2002-02-01
Expected to finish
2007-11-01
Last updated by the study team
2016-07-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.